SG Americas Securities’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Sell
21,935
-11,363
-34% -$263K ﹤0.01% 2277
2026
Q1
$797K Sell
33,298
-62,227
-65% -$1.52M ﹤0.01% 1912
2025
Q4
$2.16M Sell
95,525
-32,403
-25% -$705K ﹤0.01% 1488
2025
Q3
$2.58M Buy
127,928
+113,619
+794% +$1.9M 0.01% 824
2025
Q2
$204K Sell
14,309
-70,517
-83% -$824K ﹤0.01% 2248
2025
Q1
$891K Buy
+84,826
New +$960K ﹤0.01% 1265
2024
Q4
Sell
-16,888
Closed -$248K 3259
2024
Q3
$248K Sell
16,888
-10,881
-39% -$152K ﹤0.01% 2310
2024
Q2
$401K Buy
+27,769
New +$444K ﹤0.01% 1796
2023
Q3
Sell
-24,369
Closed -$245K 3138
2023
Q2
$245K Buy
+24,369
New +$226K ﹤0.01% 1714
2023
Q1
Sell
-75,764
Closed -$926K 3332
2022
Q4
$926K Buy
75,764
+44,172
+140% +$551K 0.01% 1026
2022
Q3
$392K Buy
31,592
+10,915
+53% +$191K ﹤0.01% 1766
2022
Q2
$406K Buy
20,677
+5,433
+36% +$129K ﹤0.01% 2141
2022
Q1
$398K Buy
+15,244
New +$406K ﹤0.01% 2025
2021
Q4
Sell
-16,017
Closed -$511K 3500
2021
Q3
$511K Sell
16,017
-43,508
-73% -$1.46M ﹤0.01% 2484
2021
Q2
$2.06M Buy
59,525
+49,534
+496% +$1.63M 0.01% 1102
2021
Q1
$294K Sell
9,991
-8,494
-46% -$261K ﹤0.01% 2394
2020
Q4
$567K Sell
18,485
-9,190
-33% -$280K ﹤0.01% 1889
2020
Q3
$773K Sell
27,675
-39,995
-59% -$1.01M ﹤0.01% 1344
2020
Q2
$1.45M Buy
67,670
+37,735
+126% +$834K 0.01% 1058
2020
Q1
$670K Sell
29,935
-86,007
-74% -$2.36M 0.01% 1588
2019
Q4
$3.41M Buy
115,942
+86,261
+291% +$2.34M 0.03% 555
2019
Q3
$789K Buy
29,681
+14,651
+97% +$440K 0.01% 1566
2019
Q2
$508K Sell
15,030
-22,591
-60% -$733K ﹤0.01% 1884
2019
Q1
$1.21M Buy
+37,621
New +$1.16M 0.01% 1158

Other funds holding ELAN

SG Americas Securities's ELAN Position: Q2 2026 in Review

SG Americas Securities reduced its Elanco Animal Health (ELAN) stake by 34% in Q2 2026, selling an estimated $263K and leaving 21,935 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

SG Americas Securities first reported a position in ELAN in Q1 2019 and has held it in 24 quarters since. The position peaked at $3.41M in Q4 2019. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • SG Americas Securities held 21,935 shares of Elanco Animal Health worth $540K as of Q2 2026.
  • SG Americas Securities sold 11,363 Elanco Animal Health shares in Q2 2026, an estimated $263K.
  • Elanco Animal Health made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2277 holding.
  • SG Americas Securities first reported a position in Elanco Animal Health in Q1 2019 and has held it in 24 quarters since.
  • SG Americas Securities's Elanco Animal Health position peaked at $3.41M in Q4 2019.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.